| Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol. | |
| | |
MedLine Citation:
|
PMID: 21050070 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Reverse cholesterol transport is the process by which extrahepatic cells, including macrophage-derived foam cells in arterial atherosclerotic plaque, transport excessive cholesterol back to the liver for bile acid synthesis and excretion, thus lowering the peripheral lipid burden. Cholesterol efflux from peripheral cells is the first step in this process, and finding drugs and interventions that promote this event is an important endeavor. Radioisotope-labeled cholesterol traditionally has been employed in measuring efflux efficiency, but this reagent has limitations for high-throughput screening. We developed an alternative method to measure cholesterol efflux in macrophage-derived foam cells using a novel fluorescent cholesterol mimic comprising the Pennsylvania Green fluorophore, attached by a linker containing a glutamic acid residue, to a derivative of N-alkyl-3β-cholesterylamine. Compared with the traditional radioisotope-based assay, this fluorescence-based assay gave similar results in the presence of known modulators of cholesterol efflux, such as cyclic AMP, and different cholesterol acceptors. When the fluorescent probe was employed in a high-throughput screening format, a variety of chemicals and bioactive compounds with known and unknown effects on cholesterol efflux could be tested simultaneously by plate-reader in a short period of time. Treatment of THP-1-derived macrophages with inhibitors of the membrane transporter ATP-binding cassette A1, such as glyburide or a specific antibody, significantly reduced the export of this fluorescent compound, indicating that ATP-binding cassette A1 represents the primary mediator of its cellular efflux. This fluorescent mimic of cholesterol provides a safe, sensitive, and reproducible alternative to radioactive assays in efflux experiments and has great potential as a valuable tool when incorporated into a drug discovery program. |
| | |
Authors:
|
Jun Zhang; Sutang Cai; Blake R Peterson; Penny M Kris-Etherton; John P Vanden Heuvel |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2010-11-04 |
Journal Detail:
|
Title: Assay and drug development technologies Volume: 9 ISSN: 1557-8127 ISO Abbreviation: Assay Drug Dev Technol Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-04-04 Completed Date: 2012-03-06 Revised Date: 2012-04-02 |
Medline Journal Info:
|
Nlm Unique ID: 101151468 Medline TA: Assay Drug Dev Technol Country: United States |
Other Details:
|
Languages: eng Pagination: 136-46 Citation Subset: IM |
Affiliation:
|
Department of Nutritional Sciences, The Pennsylvania State University, University Park, 16802, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
ATP-Binding Cassette Transporters
/
metabolism Biological Transport / physiology Cell Line Cholesterol / metabolism* Green Fluorescent Proteins / metabolism* High-Throughput Screening Assays / methods* Humans Molecular Mimicry / physiology* Monocytes / metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
R01-CA83831/CA/NCI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/ATP binding cassette transporter 1; 0/ATP-Binding Cassette Transporters; 147336-22-9/Green Fluorescent Proteins; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial hi...
Next Document: Development of cell-based high-throughput assays for the identification of inhibitors of receptor ac...